Education
About Us
Working with TipRanks
Follow Us
Surgery Partners Inc (SGRY)
NASDAQ:SGRY
Earnings Data
Report Date
May 05, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.13Last Year’s EPS
0.04Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call conveyed a mixed view: solid top-line growth (net revenue +6.2%, same-facility revenue +4.9%) and progress on strategic initiatives (orthopedic growth, robotics, physician recruitment, portfolio optimization), but material near-term operational challenges concentrated in three surgical hospital markets led to an earnings shortfall, margin compression (-40 bps), payer mix headwinds, and costs that outpaced revenue in those locales. Management emphasized these issues are identifiable and addressable and provided conservative 2026 guidance that incorporates the headwinds.Company Guidance
Revenue Growth
Full year net revenue of $3.3 billion, up 6.2% year-over-year; full-year same-facility revenue growth of 4.9%.
Adjusted EBITDA and Margin
Full year adjusted EBITDA of $526 million, up 3.5% year-over-year; adjusted EBITDA margin of 15.9% (40 basis points of margin compression year-over-year).
Case Volume and Specialty Mix
Performed nearly 670,000 surgical cases in 2025 versus 656,000 in 2024 (~2.1% increase); fourth quarter same-facility case growth of 1.3%; strong traction in orthopedics with over 42,000 orthopedic cases in Q4 — total joint cases grew 15% in Q4 and 19% year-to-date.
Physician Recruitment and Technology Investment
Recruited almost 700 physicians in 2025 and expanded surgical capabilities with 74 surgical robots in service (six added in 2025), supporting a strategic shift to higher-acuity procedures.
Capital Deployment and M&A Discipline
Deployed $182 million of acquisition capital in 2025 (modestly below target), with management noting acquisitions were made at attractive valuations and M&A pipeline remains strong; opened eight de novo facilities in 2025 (four in Q4).
Portfolio Optimization Progress
Active portfolio optimization efforts, including a Baylor Scott & White joint venture (Bryan, TX) that will deconsolidate the facility but is expected to improve run-rate earnings efficiency and support strategic alignment; management expects resolution on key actions in H1 2026.
2026 Initial Guidance
Initial 2026 guidance: net revenue $3.3 billion to $3.45 billion (single-digit growth) and adjusted EBITDA of at least $530 million (at least 0.7% growth), reflecting conservative planning that incorporates identified headwinds.
SGRY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SGRY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 02, 2026 | $15.88 | $13.92 | -12.34% |
Nov 10, 2025 | $21.50 | $16.04 | -25.40% |
Aug 05, 2025 | $22.22 | $22.14 | -0.36% |
May 12, 2025 | $22.16 | $23.26 | +4.96% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Surgery Partners Inc (SGRY) report earnings?
Surgery Partners Inc (SGRY) is schdueled to report earning on May 05, 2026, Before Open (Confirmed).
What is Surgery Partners Inc (SGRY) earnings time?
Surgery Partners Inc (SGRY) earnings time is at May 05, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SGRY EPS forecast?
SGRY EPS forecast for the fiscal quarter 2026 (Q1) is -0.13.